Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
33.06 CHF | +2.43% | -0.03% | +21.69% |
06-14 | Sandoz AG Re-Submits the Biosimilar Drug EG12014 (Trastuzumab Biosimilar) 150 Mg Powder BLA to the US FDA | CI |
06-07 | AbbVie's tight grip on Humira market raises concerns about biosimilars | RE |
Past dividends on Sandoz Group AG
2024-05-02 | Annual 0.45 CHF |
- Stock Market
- Equities
- SDZ Stock
- Charts Sandoz Group AG
- Total Return chart